LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway

Published:2022-07-06 Issue:3 Volume:149 Page:1295-1311
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Shi Wenjing,Ling Liqun,Li Changhong,Wu Ruihao,Zhang Meijuan,Shao Fanggui,Wang Yumin

Funder

the Wenzhou Science and Technology Bureau

National Natural Science Foundation of China

Scientific Research Fund of Zhejiang Provincial Education Department

Zhejiang Provincial Research Center for Cancer Intelligent Diagnosis and Molecular Technology

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04152-5.pdf

Reference35 articles.

1. Alfonso-Prieto M, Biarnés X, Vidossich P, Rovira C (2009) The molecular mechanism of the catalase reaction. J Am Chem Soc 131:11751–11761. https://doi.org/10.1021/ja9018572

2. Banks CJ, Andersen JL (2019) Mechanisms of SOD1 regulation by post-translational modifications. Redox Biol 26:101270. https://doi.org/10.1016/j.redox.2019.101270

3. Chen Y, Li Z, Chen X, Zhang S (2021) Long non-coding RNAs: from disease code to drug role. Acta Pharm Sin B 11:340–354. https://doi.org/10.1016/j.apsb.2020.10.001

4. Chiang S-K, Chen S-E, Chang L-C (2018) A dual role of heme oxygenase-1 in cancer cells. Int J Mol Sci 20:E39. https://doi.org/10.3390/ijms20010039

5. Consonni FM, Bleve A, Totaro MG, Storto M, Kunderfranco P, Termanini A, Pasqualini F, Alì C, Pandolfo C, Sgambelluri F, Grazia G, Santinami M, Maurichi A, Milione M, Erreni M, Doni A, Fabbri M, Gribaldo L, Rulli E, Soares MP, Torri V, Mortarini R, Anichini A, Sica A (2021) Heme catabolism by tumor-associated macrophages controls metastasis formation. Nat Immunol 22:595–606. https://doi.org/10.1038/s41590-021-00921-5

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression;International Journal of Molecular Sciences;2024-08-19

2. Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer;Frontiers in Oncology;2024-04-03

3. The molecular mechanisms of various long non-coding RNA (lncRNA) in human lung tumors: Shedding light on the molecular mechanisms;Pathology - Research and Practice;2024-04

4. Comprehensive analysis of m6A modification patterns and m6A‐related lncRNAs as potential biomarkers in lung adenocarcinoma;Environmental Toxicology;2023-12-26

5. Long non-coding RNA and Evolving drug resistance in lung cancer;Heliyon;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3